Viewing Study NCT03197506


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-01-13 @ 11:05 AM
Study NCT ID: NCT03197506
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-06
First Post: 2017-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module